Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting
Clinical trial NCT02717962 · COMPLETED
Trial details
- NCT number
- NCT02717962
- Sponsor
- Kintara Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-20
- Primary completion
- 2024-12-30
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.